Expression and regulation of connective tissue growth factor by transforming growth factor β and tumour necrosis factor α in fibroblasts isolated from strictures in patients with Crohn's disease

British Journal of Surgery

Volumn 93, Issue 10, 2006, Pages 1290-1296

  Beddy, D ^a   Mulsow, J ^a   Watson, R W G ^a   Fitzpatrick, J M ^a   O'Connell, P R ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOPSY; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL DISEASE; COLORECTAL SURGERY; CONTROLLED STUDY; CROHN DISEASE; FIBROBLAST; HOMEOSTASIS; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CROHN DISEASE; FIBROBLASTS; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33749599530     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.5431     Document Type: Article

References (27)

1. Peltonen J, Kahari L, Uitto J, Jimenez SA. Increased expression of type IV collagen genes in systemic sclerosis. Arthritis Rheum 1990; 33: 1829-1835.
2. Gruschwitz M, Muller PU, Sepp N, Hofer E, Fontana A, Wick G. Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J Invest Dermatol 1990; 94: 197-203.
3. Dammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: a novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998; 30: 909-922.
4. Farmer RG, Whelan G, Fazio VW. Long-term follow-up of patients with Crohn's disease. Relationship between the clinical patterns and prognosis. Gastroenterology 1985; 88: 1818-1825.
5. Graham MF, Diegelmann R, Elson CO, Lindblad W, Gotschalk N, Gay S et al. Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 1988; 94: 257-265.
6. Stallmach A, Schuppan D, Riese HH, Matthes H, Riecken E. Increased collagen type III synthesis by fibroblasts isolated from strictures of patients with Crohn's disease. Gastroenterology 1992; 102: 1920-1929.
7. Beddy D, Watson RWG, Fitzpatrick JM, O'Connell PR. Increased vascular endothelial growth factor production in fibroblasts isolated from strictures in patients with Crohn's disease. Br J Surg 2004; 91: 72-77.
8. Brannigan AE, Watson RW, Beddy D, Hurley H, Fitzpatrick JM, O'Connell PR. Increased adhesion molecule expression in serosal fibroblasts isolated from patients with inflammatory bowel disease is secondary to inflammation. Ann Surg 2002; 235: 507-511.
9. Beddy DJ, Watson RW, Fitzpatrick JM, O'Connell PR. Critical involvement of stress-activated mitogen-activated protein kinases in the regulation of intercellular adhesion molecule-1 in serosal fibroblasts isolated from patients with Crohn's disease. J Am Coll Surg 2004; 199: 234-242.
10. Regan MC, Flavin BM, Fitzpatrick JM, O'Connell PR. Stricture formation in Crohn's disease: the role of intestinal fibroblasts. Ann Surg 2000; 231: 46-50.
11. Frazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404-411.
12. Blom IE, van Dijk AJ, Wieten L, Duran K, Ito Y, Kleij L et al. In vitro evidence for differential involvement of CTGF, TGF-β and PDGF-BB in mesangial response to injury. Nephrol Dial Transplant 2001; 16: 1139-1148.
13. Holmes A, Abraham D, Sa S, Shiwen X, Black C, Leask A. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling. J Biol Chem 2001; 276: 10594-10601.
14. Abou-Shady M, Friess H, Zimmermann A, di Mola FF, Guo XZ, Baer HU et al. Connective tissue growth factor in human liver cirrhosis. Liver 2000; 20: 296-304.
15. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Grotendorst G et al. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis. J Invest Dermatol 1995; 105: 280-284.
16. Igarashi A, Nashiro K, Kikuchi K, Sato S, Ihn H, Fujimoto M et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996; 106: 729-733.
17. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F et al. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 1999; 274: 5830-5834.
18. Stack WA, Mann SD, Roy AJ, Heath P, Sopwith M, Freeman J et al. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease. Lancet 1997; 349: 521-524.
19. Targan SR, Hanauer SB, Deventer SJ, Mayer L, Present DH, Braakman T et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group. N Engl J Med 1997; 337: 1029-1035.
20. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340: 1398-1405.
21. Poritz LS, Rowe WA, Koltun WA. Remicade does not abolish the need for surgery in fistulizing Crohn's disease. Dis Colon Rectum 2002; 45: 771-775.
22. Van Assche G, Geboes K, Rutgeerts P. Medical therapy for Crohn's disease strictures. Inflamm Bowel Dis 2004; 10: 55-60.
23. Lin J, Liliensiek B, Kanitz M, Schimanski U, Bohrer H, Waldherr R et al. Molecular cloning of genes differentially regulated by TNF-α in bovine aortic endothelial cells, fibroblasts and smooth muscle cells. Cardiovasc Res 1998; 38: 802-813.
24. Abraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. TNF-α suppresses the induction of connective tissue growth factor by transforming growth factor-beta in normal and scleroderma fibroblasts. J Biol Chem 2000; 275: 15220-15225.
25. Kikuchi K, Kadono T, Ihn H, Sato S, Igarashi A, Nakgawa H et al. Growth factor regulation in scleroderma fibroblasts: increased response to transforming growth factor-beta1. J Invest Dermatol 1995; 105: 128-132.
26. Sato S, Nagaoka T, Hasegawa M, Tamatani T, Nakanishi T, Takigawa M et al. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. J Rheumatol 2000; 27: 149-154.
27. Pucilowska JB, McNaughton KK, Mohapatra NK, Hoyt EC, Zimmerman EM, Sartor RB et al. IGF-1 and procollagen α1(1) are coexpressed in a subset of mesenchymal cells in active Crohn's disease. Am J Physiol Gastrointest Liver Physiol 2000; 279: G1307-G1322.